Mindset Pharma Inc.

10 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Feb 2041

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 14, 2027.

Recent changes

1 of the patents on this record was granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Patent	Title	Status	Expires	Confidence
US 11,427,604	Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Term ends Feb 4, 2041 · High confidence	In force	Term ends Feb 4, 2041	High confidence
US 11,453,689	3-Pyrrolidine-INDOLE Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Term ends Feb 4, 2041 · High confidence	In force	Term ends Feb 4, 2041	High confidence
US 11,591,353	Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Ends no later than Feb 4, 2041 · Medium confidence	In force	Ends no later than Feb 4, 2041	Medium confidence
US 11,597,738	Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Term ends Feb 4, 2041 · High confidence	In force	Term ends Feb 4, 2041	High confidence
US 12,054,504	3-Pyrrolidine-INDOLE Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Term ends Feb 4, 2041 · High confidence	In force	Term ends Feb 4, 2041	High confidence
US 12,054,505	Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Ends no later than Feb 4, 2041 · Medium confidence	In force	Ends no later than Feb 4, 2041	Medium confidence
US 12,378,266	Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Term ends Feb 4, 2041 · High confidence	In force	Term ends Feb 4, 2041	High confidence
US 12,760,045	3-Pyrrolidine-INDOLE Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders In force Term ends Feb 4, 2041 · Low confidence	In force	Term ends Feb 4, 2041	Low confidence
US 12,590,060	Scalable Synthetic Route for Psilocin and Psilocybin In force Term ends Jan 30, 2043 · High confidence	In force	Term ends Jan 30, 2043	High confidence
US 12,606,543	Indole Derivatives as Serotonergic Agents Useful for the Treatment of Disorders Related Thereto In force Term ends Nov 12, 2044 · High confidence	In force	Term ends Nov 12, 2044	High confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 2 abandoned · 1 no status recorded

List them